Please login to the form below

Not currently logged in
Email:
Password:

Hikma

This page shows the latest Hikma news and features for those working in and with pharma, biotech and healthcare.

GSK gets maintenance indication for Trelegy

GSK gets maintenance indication for Trelegy

copycat versions from Mylan, Hikma and Novartis.

Latest news

More from news
Approximately 6 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • The human perspective The human perspective

    Chief among these moves were the German company's exit from the generics business, via a $2.6bn deal with specialty firm Hikma, and its forthcoming asset swap with Sanofi.

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    348. Bedford Labs (Boehringer Ingelheim) / Hikma. Asset / product acquisition.

  • Pharma deals during May 2014 Pharma deals during May 2014

    Hikma, the Jordanian generic company, acquired the assets of the US-based Bedford Labs (owned by Boehringer Ingelheim), a generic injectable manufacturer, for $300m (16 x sales).

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    Hikma Pharmaceuticals appoints VP, sales and marketing, Generics. Kristy Ronco has been appointed as vice president, sales and marketing, generics for Hikma Pharmaceuticals. ... Ronco joins Hikma after more than a decade at Zydus Pharmaceuticals, where

  • Sigurdur Olafsson becomes CEO of Hikma Sigurdur Olafsson becomes CEO of Hikma

    Sigurdur Olafsson becomes CEO of Hikma. And Said Darwazah is appointed as executive chairman. ... Said Darwazah, Hikma’s recently appointed executive chairman, said: “We are delighted that Sigurdur is joining Hikma as out new CEO.

  • Hikma appoints group scientific officer and global head of R&D Hikma appoints group scientific officer and global head of R&D

    Hikma appoints group scientific officer and global head of R&D. Dr Surendera Tyagi joins the pharma group from Fresenius Kabi. ... Speciality pharmaceutical group Hikma has appointed a group scientific officer and gloval head of R&D in the form of Dr

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Congress Effectiveness Management
Maximising the ROI of scientific meetings...
Shanghai
Biopharma's Future: Made in China
The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...

Infographics